Stanford’s James Zou, known for his FDA-cleared cardiac AI project EchoNet, is now spearheading a new venture named Human Intelligence. The startup is focused on applying AI technology to advance research on the human body. With cutting-edge achievements including a Virtual Lab that designs novel nanobodies and a Virtual Biotech initiative, Zou is reportedly seeking $100 million in funding at a valuation near $1 billion, according to Bloomberg reports.
Back
